Intranasal Ketamine and Cognitive-Behavioral Therapy for Treatment-Refractory Obsessive-Compulsive Disorder

J Clin Psychopharmacol. 2017 Apr;37(2):269-271. doi: 10.1097/JCP.0000000000000659.

Authors

Thomas G Adams¹, Michael H Bloch, Christopher Pittenger

Affiliation

¹ Department of Psychiatry, Yale University School of Medicine, New Haven, CT [email protected]; Department of Psychiatry and Child Study Center, Yale University School of Medicine, New Haven, CT; Department of Psychiatry and Child Study Center and Department of Psychology, Interdepartmental Neuroscience Program, Yale University School of Medicine, New Haven, CT.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Intranasal
Adult
Antidepressive Agents / administration & dosage
Antidepressive Agents / pharmacology*
Cognitive Behavioral Therapy / methods*
Combined Modality Therapy
Depressive Disorder, Major / drug therapy
Depressive Disorder, Major / therapy*
Humans
Ketamine / administration & dosage
Ketamine / pharmacology*
Male
Obsessive-Compulsive Disorder / drug therapy
Obsessive-Compulsive Disorder / therapy*
Young Adult

Substances

Antidepressive Agents
Ketamine

Grants and funding